Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep939 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Screening and quantification of hepatic steatosis in obese patients using the controlled attenuation parameter (CAP)

Mohamed Nefzi Ahmed , Dhouha Cherif , Fatma Kahlaoui , Habiba Dabbebi , Haythem Yacoub , Hajer Hassine , Hela Kchir , Nadia Maamouri

Introduction: Liver steatosis currently represents a hepatic manifestation of metabolic syndrome. It occurs more frequently in patients with obesity, and liver biopsy remains the gold standard for the positive diagnosis of this condition. In recent decades, the positive diagnosis of hepatic steatosis has increasingly relied on non-invasive methods such as Controlled Attenuation Parameter (CAP). The objective of this study was to investigate the prevalence of hepatic steatosis ...